News

GLOBAL TRIALS : New Survey Baselines Global Sites Keys to Success in China Budgeting for Global Trials European Ethics Committees CRO/SPONSOR : Think About the Drug Label First LABS : 3-Prong Model for CV Safety Immune Response Screens a Necessity eCLINICAL : ePRO?s Tipping Point Also in this issue : FDA?s New Risk Approach to Site Inspections, EMA Speaks to Stem Cell Research, Mother Lode of Latent Research Data

Industry news focusing on the people and organizations who work in the clinical trials profession.

Overcoming method validation challenges for trial populations during biologic drug development.

The financial advantages of using ePRO over paper-based diaries when conducting clinical trials.

Updates on the respiratory therapeutic market.

On several occasions each year, Industry Standard Research (ISR) has the opportunity to speak with sponsor companies about their outsourcing practices.

S

What it can mean for the future of health care studies and how it can benefit clinical trials' patients.